Nexus Uranium Corp
F:JA7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nexus Uranium Corp
F:JA7
|
CA |
|
T
|
TWC Enterprises Ltd
TSX:TWC
|
CA |
|
S
|
Solid FAB
STO:SFAB
|
SE |
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
US |
|
Repro Med Systems Inc
NASDAQ:KRMD
|
US |
|
Cellularline SpA
MIL:CELL
|
IT |
|
Aker Carbon Capture ASA
OTC:AKCCF
|
NO |
|
Arhaus Inc
NASDAQ:ARHS
|
US |
|
Moleculin Biotech Inc
NASDAQ:MBRX
|
US |
|
S
|
Sparebank 1 Ringerike Hadeland
OSE:RING
|
NO |
|
S
|
Spectrum Pharmaceuticals Inc
F:NTR
|
US |
|
K
|
Klaipedos Nafta AB
F:XIC
|
LT |
|
Iridium Communications Inc
NASDAQ:IRDM
|
US |
|
Global Brokerage Inc
OTC:GLBR
|
US |
|
V
|
Vuno Inc
KOSDAQ:338220
|
KR |
Income Statement
Earnings Waterfall
Nexus Uranium Corp
Income Statement
Nexus Uranium Corp
| May-2020 | Aug-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(2)
|
(3)
|
(5)
|
(5)
|
(3)
|
(3)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(6)
|
(6)
|
(4)
|
(5)
|
(1)
|
(1)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(2)
|
(3)
|
(5)
|
(5)
|
(3)
|
(3)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(6)
|
(6)
|
(4)
|
(4)
|
(1)
|
(1)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(0)
-9%
|
(2)
-914%
|
(3)
-52%
|
(5)
-61%
|
(5)
-12%
|
(3)
+51%
|
(3)
-5%
|
(1)
+58%
|
(1)
+45%
|
(1)
-12%
|
(1)
+13%
|
(1)
-134%
|
(2)
-3%
|
(2)
-3%
|
(3)
-114%
|
(6)
-73%
|
(6)
-3%
|
(4)
+32%
|
(5)
-17%
|
(1)
+72%
|
(1)
-5%
|
|
| Pre-Tax Income | |||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
(9)
|
(0)
|
0
|
8
|
1
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(9)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(9)
|
(9)
|
(9)
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
-9%
|
(2)
-914%
|
(3)
-52%
|
(5)
-61%
|
(5)
-12%
|
(3)
+52%
|
(3)
-8%
|
(1)
+58%
|
(1)
+48%
|
(1)
-56%
|
(1)
+11%
|
(2)
-101%
|
(2)
-5%
|
(2)
+14%
|
(3)
-116%
|
(14)
-317%
|
(15)
-8%
|
(13)
+15%
|
(13)
-4%
|
(2)
+85%
|
(9)
-362%
|
|
| Net Income | |||||||||||||||||||||||
| Income from Continuing Operations |
(0)
|
(0)
|
(2)
|
(3)
|
(5)
|
(5)
|
(3)
|
(3)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(14)
|
(15)
|
(13)
|
(13)
|
(2)
|
(9)
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
-9%
|
(2)
-914%
|
(3)
-52%
|
(5)
-61%
|
(5)
-12%
|
(3)
+52%
|
(3)
-8%
|
(1)
+58%
|
(1)
+48%
|
(1)
-56%
|
(1)
+11%
|
(2)
-101%
|
(2)
-5%
|
(2)
+14%
|
(3)
-116%
|
(14)
-317%
|
(15)
-8%
|
(13)
+15%
|
(13)
-4%
|
(2)
+85%
|
(9)
-362%
|
|
| EPS (Diluted) |
-1.77
N/A
|
-1.93
-9%
|
-16.37
-748%
|
-11.84
+28%
|
-14.33
-21%
|
-13.02
+9%
|
-6.92
+47%
|
-6.62
+4%
|
-2.77
+58%
|
-1.43
+48%
|
-2.24
-57%
|
-1.89
+16%
|
-1.17
+38%
|
-0.95
+19%
|
-1.05
-11%
|
-1.5
-43%
|
-5.85
-290%
|
-6.34
-8%
|
-4.68
+26%
|
-3.31
+29%
|
-0.46
+86%
|
-2.14
-365%
|
|